Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Epilepsy & Behavior

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yebeh.2010.08.007PMID 20833111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic predisposition of life-threatening antiepileptic-induced skin reactions

  2010cited by this paper
• HLA Class I markers in Japanese patients with carbamazepine‐induced cutaneous adverse reactions

  2010cited by this paper
• Genetic basis for idiosyncratic reactions to antiepileptic drugs

  2009cited by this paper
• Genetic structure of the Han Chinese population revealed by genome-wide SNP variation.

  2009cited by this paper
• Human leukocyte antigen genotypes in carbamazepine‐induced severe cutaneous adverse drug response in Japanese patients

  2008cited by this paper
• Adverse Effects of Antiepileptic Drugs

  2008cited by this paper
• Carbamazepine and phenytoin induced Stevens‐Johnson syndrome is associated with HLA‐B*1502 allele in Thai population

  2008cited by this paper
• Human leukocyte antigens and drug hypersensitivity

  2007cited by this paper
• Comparison and predictors of rash associated with 15 antiepileptic drugs

  2007cited by this paper
• Association between HLA‐B*1502 Allele and Antiepileptic Drug‐Induced Cutaneous Reactions in Han Chinese

  2007cited by this paper
• Rash from Antiepileptic Drugs: Influence by Gender, Age, and Learning Disability

  2007cited by this paper
• A marker for Stevens-Johnson syndrome …: ethnicity matters

  2006cited by this paper
• HLA-B locus in Caucasian patients with carbamazepine hypersensitivity.

  2006cited by this paper
• Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions

  2006cited by this paper
• Predictors of Lamotrigine‐associated Rash

  2006cited by this paper
• HLA-B genotyping to detect carbamazepine-induced Stevens-Johnson syndrome: implications for personalizing medicine.

  2005cited by this paper
• MRI of segmental zoster paresis

  2005cited by this paper
• A marker for Stevens–Johnson syndrome

  2004cited by this paper
• Cutaneous drug reactions.

  2001cited by this paper
• Lamotrigine‐Associated Rash: Risk/Benefit Considerations in Adults and Children

  1999cited by this paper
• Safety of Long‐Term Lamotrigine in Epilepsy

  1997cited by this paper
• Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: A record linkage study

  1997cited by this paper
• Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group.

  1995cited by this paper
• The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification.

  1994cited by this paper

• Molecular docking to investigate HLA-associated idiosyncratic drug reactions

  2025cites this paper
• Ocular administration of brinzolamide leading to Stevens-Johnson syndrome/toxic epidermal necrolysis overlap: A case report and review

  2025cites this paper
• Updates in the pathogenesis of SJS/TEN

  2025cites this paper
• A comprehensive update on the human leukocyte antigen and idiosyncratic adverse drug reactions

  2025cites this paper
• Meta-Analysis of the Association of HLA-B*15:02 with Aromatic Antiepileptic Drugs Inducing SJS/TEN

  2024cites this paper
• Stevens–Johnson syndrome and toxic epidermal necrolysis: Updates in pathophysiology and management

  2024cites this paper
• Unraveling the genetic link: an umbrella review on HLA-B*15:02 and antiepileptic drug-induced Stevens–Johnson syndrome/toxic epidermal necrolysis

  2024cites this paper
• Carbamazepine cutaneous adverse reactions and HLA gene variation in the Chinese population: a systematic review and meta-analysis.

  2023cites this paper
• Associations of HLA genetic variants with carbamazepine‐induced cutaneous adverse drug reactions: An updated meta‐analysis

  2022cites this paper
• rs144012689 is a highly specific representative marker of HLA-B*15:02 in the Chinese population.

  2022cites this paper
• DỊ ỨNG CARBAMAZEPINE VÀ MỐI LIÊN QUAN VỚI SỰ CÓ MẶT CỦA ALLELE HLA-B*15:02 VÀ HLA-A*31:01 TẠI BỆNH VIỆN TÂM ANH

  2022cites this paper
• Genetic markers of drug hypersensitivity in pediatrics: current state and promise

  2022cites this paper
• Pharmacogenomics of Drug Hypersensitivity: Technology and Translation.

  2022cites this paper
• Epilepsy in China: major progress in the past two decades.

  2021cites this paper
• Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model

  2021cites this paper
• Current Pharmacogenetic Perspective on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

  2021cites this paper
• Ongoing Initiatives in Bringing the Preemptive Panel—Based Pharmacogenetic Testing to Clinical Decisions in Vietnam

  2021cites this paper
• Epilepsy in China: major leaps in the last two decades

  2021cites this paper
• Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis

  2020cites this paper
• Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA‐compliant systematic review—An EAACI position paper

  2020cites this paper
• Association of carbamazepine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients

  2020cites this paper
• An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects

  2020cites this paper
• Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)

  2020cites this paper
• Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines

  2020cites this paper
• Association between HLA genotype and antiseizure medications (ASMs)-induced maculopapular eruption among epilepsy patients in Xinjiang, China.

  2020cites this paper
• Developing pharmacogenetic screening methods for an emergent country: Vietnam

  2019cites this paper
• Human leukocyte antigen-associated severe cutaneous adverse drug reactions: from bedside to bench and beyond

  2019cites this paper
• Carbamazepine-Induced Stevens–Johnson Syndrome and HLA-B*1502 Screening among First-degree Relatives of Index Patients

  2019cites this paper
• HLA‐associated antiepileptic drug‐induced cutaneous adverse reactions

  2019cites this paper
• Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest China

  2019cites this paper
• Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity

  2019cites this paper
• Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.

  2019cites this paper
• Recent developments in drug hypersensitivity in children

  2019cites this paper
• Diagnostic Utility of Human Leukocyte Antigen B*15:02 Screening in Severe Carbamazepine Hypersensitivity Syndrome

  2019influential citation
• Cost‐effectiveness of screening for HLA‐B*1502 prior to initiation of carbamazepine in epilepsy patients of Asian ancestry in the United States

  2019cites this paper
• An update on HLA alleles as pharmacogenetic markers for antiepileptic drug-induced cutaneous adverse reaction

  2019influential citation
• Pharmacogenomics: A New Approach for Preventing Severe Cutaneous Adverse Drug Reactions

  2018cites this paper
• Association between HLA-B*46: 01 and cutaneous adverse drug reactions in Han Chinese

  2018cites this paper
• SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation.

  2018cites this paper
• The HLA-B*15:02 polymorphism and Tegretol®-induced serious cutaneous reactions in epilepsy: An updated systematic review and meta-analysis.

  2018cites this paper
• Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention

  2018cites this paper
• External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy

  2018cites this paper
• Allergy to chlorpromazine and valproic acid following carbamazepine hypersensitivity in a patient with an HLA-B*4601 allele

  2018cites this paper
• Association of CYP2C9*3 with phenytoin‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta‐analysis

  2018cites this paper
• Drug-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Call for Optimum Patient Stratification and Theranostics via Pharmacogenomics.

  2018cites this paper
• HLAs: Key regulators of T‐cell‐mediated drug hypersensitivity

  2018cites this paper
• Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype

  2018cites this paper
• Hypersensitivity Reactions to Antiepileptic Drugs in Children: Epidemiologic, Pathogenetic, Clinical, and Diagnostic Aspects.

  2018cites this paper
• Rapid and reliable screening of HLA-B*15:02 in four Chinese populations using single-tube multiplex real-time PCR assay.

  2017cites this paper
• The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions

  2017cites this paper
• Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study

  2017cites this paper
• HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.

  2017cites this paper
• Pharmacogenetics of hypersensitivity drug reactions.

  2017cites this paper
• An update on HLA alleles associated with adverse drug reactions

  2017cites this paper
• A novel multiplex polymerase chain reaction assay for detection of both HLA‐A*31:01/HLA‐B*15:02 alleles, which confer susceptibility to carbamazepine‐induced severe cutaneous adverse reactions

  2017cites this paper
• Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

  2017cites this paper
• Pharmacogenomics of off‐target adverse drug reactions

  2017cites this paper
• Drug-induced hypersensitivity syndrome caused by valproic acid as a monotherapy for epilepsy: First case report in Asian population

  2017cites this paper
• Pharmacogenomic testing: aiding in the management of psychotropic therapy for adolescents with autism spectrum disorders

  2017cites this paper
• Validation of a novel real-time PCR assay for detection of HLA-B*15:02 allele for prevention of carbamazepine - Induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in individuals of Asian ancestry.

  2016cites this paper
• Psychometric Validation of the Spanish Version of the DHRQoL Questionnaire.

  2016cites this paper
• Evaluation of Tolerance in Patients With Type-1 Hypersensitivity Reaction to Wheat After Oral Immunotherapy.

  2016cites this paper
• Is Vitamin D Deficiency a Marker of Severity of Wheezing in Children? A Cross-sectional Study.

  2016cites this paper
• Yogurt in the Treatment of β-Lactoglobulin-Induced Gastrointestinal Cow's Milk Allergy.

  2016cites this paper
• A Protocol for Induction of Tolerance to Apomorphine in Patients With Parkinson Disease and Hypersensitivity to Apomorphine.

  2016cites this paper
• Hypersensitivity to Quail Egg Proteins: What About Hen Egg?

  2016cites this paper
• Cross-reactivity in AED-Induced Severe Cutaneous Adverse Reaction: A Case Report.

  2016cites this paper
• Aquagenic Urticaria: Report of a Case in an Adolescent Girl.

  2016cites this paper
• Therapeutic Potential of Zoledronate-Activated Autologous γδT Cells in Atopic Dermatitis.

  2016cites this paper
• Successful Desensitization to Irinotecan After Severe Hypersensitivity Reaction.

  2016cites this paper
• PharmGKB summary: very important pharmacogene information for human leukocyte antigen B

  2015cites this paper
• Antiepileptic drugs and adverse skin reactions: An update

  2015cites this paper
• Genetics of Immune-Mediated Adverse Drug Reactions: a Comprehensive and Clinical Review

  2015cites this paper
• HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in Vietnamese

  2015cites this paper
• Association of HLA‐B*1502 allele with lamotrigine‐induced Stevens–Johnson syndrome and toxic epidermal necrolysis in Han Chinese subjects: a meta‐analysis

  2015cites this paper
• Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

  2015cites this paper
• Recommendations for HLA‐B*15:02 and HLA‐A*31:01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions

  2014cites this paper
• Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs

  2014cites this paper
• Association of HLA-B*1502 and *1511 allele with antiepileptic drug-induced Stevens-Johnson syndrome in central China

  2014cites this paper
• Genetic predictors of Stevens-Johnson syndrome and toxic epidermal necrolysis induced by aromatic antiepileptic drugs among the Chinese Han population.

  2014cites this paper
• Hypersensitivity to antiepileptic drugs.

  2014cites this paper
• Rapid detection of HLA‐A*31:01 allele in DNA and blood samples using loop‐mediated isothermal amplification

  2014cites this paper
• Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA-B*4403 allele and lamotrigine

  2014cites this paper
• Ancestry-based pharmacogenomics, adverse reactions and carbamazepine: is the FDA warning correct?

  2014cites this paper
• Pharmacogenetics of antiepileptic drug-induced hypersensitivity.

  2014cites this paper
• HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis

  2014cites this paper
• Screening for 392 polymorphisms in 141 pharmacogenes.

  2014cites this paper
• Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine‐induced Stevens‐Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy

  2014cites this paper
• Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity

  2014cites this paper
• Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.

  2014cites this paper
• Multiple Drug Induced Hypersensitivity Syndrome Reactions in a Patient with Drugs that Have Known HLA Associations for Reactions

  2014cites this paper
• HLA and the Pharmacogenomics of Drug Hypersensitivity

  2014cites this paper
• Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China

  2013cites this paper
• The association between oxcarbazepine-induced maculopapular eruption and HLA-B alleles in a Northern Han Chinese population

  2013cites this paper
• Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

  2013cites this paper
• HLA‐B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese

  2013cites this paper
• HLA-A*31:01 and HLA-B*15:02 as genetic markers for carbamazepine hypersensitivity in children

  2013cites this paper
• Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese.

  2013cites this paper
• Cost minimization of HLA-B*1502 screening before prescribing carbamazepine in Thailand

  2013cites this paper
• Developing a data mining approach to investigate association between physician prescription and patient outcome - A study on re-hospitalization in Stevens-Johnson Syndrome

  2013cites this paper